₹32.4*
MRP ₹36
10% off
₹30.6*
MRP ₹36
15% CB
₹5.4 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Prescription drugWhats That
Composition :
GENTAMICIN-0.3%W/V
Manufacturer/Marketer :
Ridley Life Science Pvt Ltd
Consume Type :
EYE/EAR
Return Policy :
Not Returnable
Expires on or after :
Secure Payment
Trusted by 8 Crore Indians
Genuine Products
Author Details
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Alcohol
Caution
Alcohol consumption may worsen the side effects like dizziness; hence please avoid or limit alcohol intake while being treated with Gentarid Eye/Ear Drops.
Pregnancy
Caution
It is advised to consult your doctor if you plan to conceive or are already pregnant before starting Gentarid Eye/Ear Drops.
Breast Feeding
Caution
There are limited studies on how Gentarid Eye/Ear Drops affects breastfed infants. Please consult your doctor before using Gentarid Eye/Ear Drops if you are breastfeeding.
Driving
Caution
Gentarid Eye/Ear Drops may cause side effects like blurry vision or dizziness, affecting your driving ability. Do not drive or operate machinery in such cases. Drive only when you are alert and have clear vision.
Liver
Caution
Let your doctor know if you have any history of liver diseases or hepatic impairment before starting Gentarid Eye/Ear Drops.
Kidney
Caution
Let your doctor know if you have any history of kidney diseases before starting Gentarid Eye/Ear Drops.
Children
Caution
Gentarid Eye/Ear Drops should be used for children only when advised by a doctor.
Product Substitutes
coupon
Drug-Drug Interactions
GentamicinRocuronium bromide
Severe
GentamicinHuman immunoglobulin
Severe
Drug-Drug Interactions
Login/Sign Up
GentamicinRocuronium bromide
Severe
How does the drug interact with Gentarid Eye/Ear Drops 10 ml:
When Rocuronium is used with Gentarid Eye/Ear Drops 10 ml, it can make the treatment more effective.
How to manage the interaction:
Co-administration of Rocuronium bromide with Gentarid Eye/Ear Drops 10 ml can possibly result in an interaction, but it can be taken if a doctor has advised it. Do not discontinue any medications without consulting a doctor.
When Rocuronium is used with Gentarid Eye/Ear Drops 10 ml, it can make the treatment more effective.
How to manage the interaction:
Co-administration of Rocuronium bromide with Gentarid Eye/Ear Drops 10 ml can possibly result in an interaction, but it can be taken if a doctor has advised it. Do not discontinue any medications without consulting a doctor.
GentamicinHuman immunoglobulin
Severe
How does the drug interact with Gentarid Eye/Ear Drops 10 ml:
Co-administration of Human immunoglobulin with Gentarid Eye/Ear Drops 10 ml may raise the risk of kidney problems.
How to manage the interaction:
Although taking Human immunoglobulin and Gentarid Eye/Ear Drops 10 ml together can cause an interaction, it can be taken if a doctor has suggested it. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Co-administration of Human immunoglobulin with Gentarid Eye/Ear Drops 10 ml may raise the risk of kidney problems.
How to manage the interaction:
Although taking Human immunoglobulin and Gentarid Eye/Ear Drops 10 ml together can cause an interaction, it can be taken if a doctor has suggested it. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
GentamicinMagnesium sulfate
Severe
How does the drug interact with Gentarid Eye/Ear Drops 10 ml:
Co-administration of Magnesium sulfate with Gentarid Eye/Ear Drops 10 ml can increase the risk of muscle weakness.
How to manage the interaction:
Although there is a possible interaction between Magnesium sulfate and Gentarid Eye/Ear Drops 10 ml, you can take these medicines together if prescribed by a doctor. However, consult a doctor if you experience muscle weakness and breathing difficulties. Do not stop using any medications without talking to a doctor.
Co-administration of Magnesium sulfate with Gentarid Eye/Ear Drops 10 ml can increase the risk of muscle weakness.
How to manage the interaction:
Although there is a possible interaction between Magnesium sulfate and Gentarid Eye/Ear Drops 10 ml, you can take these medicines together if prescribed by a doctor. However, consult a doctor if you experience muscle weakness and breathing difficulties. Do not stop using any medications without talking to a doctor.
GentamicinMetrizamide
Severe
How does the drug interact with Gentarid Eye/Ear Drops 10 ml:
Co-administration of Metrizamide with Gentarid Eye/Ear Drops 10 ml may increase the risk of kidney problems.
How to manage the interaction:
Taking Gentarid Eye/Ear Drops 10 ml with Metrizamide together can possibly result in an interaction, but it can be taken if your doctor has advised it. It's important to keep an eye on how much you pee. If you notice any changes, like peeing more or less than usual, it's a good idea to let a doctor know right away. Other symptoms to watch out for include feeling sick, throwing up, not wanting to eat, gaining or losing weight suddenly, or having trouble with your muscles, balance, or heart rhythm. Do not stop using any medications without a doctor's advice.
Co-administration of Metrizamide with Gentarid Eye/Ear Drops 10 ml may increase the risk of kidney problems.
How to manage the interaction:
Taking Gentarid Eye/Ear Drops 10 ml with Metrizamide together can possibly result in an interaction, but it can be taken if your doctor has advised it. It's important to keep an eye on how much you pee. If you notice any changes, like peeing more or less than usual, it's a good idea to let a doctor know right away. Other symptoms to watch out for include feeling sick, throwing up, not wanting to eat, gaining or losing weight suddenly, or having trouble with your muscles, balance, or heart rhythm. Do not stop using any medications without a doctor's advice.
GentamicinTenofovir alafenamide
Severe
How does the drug interact with Gentarid Eye/Ear Drops 10 ml:
Co-administration of Tenofovir alafenamide may cause kidney problems and combining it Gentarid Eye/Ear Drops 10 ml may increase that risk.
How to manage the interaction:
Although there is a possible interaction, Gentarid Eye/Ear Drops 10 ml can be taken with tenofovir alafenamide if prescribed by the doctor. Consult the doctor if you experience signs and symptoms of kidney damage such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not stop using any medications without consulting a doctor.
Co-administration of Tenofovir alafenamide may cause kidney problems and combining it Gentarid Eye/Ear Drops 10 ml may increase that risk.
How to manage the interaction:
Although there is a possible interaction, Gentarid Eye/Ear Drops 10 ml can be taken with tenofovir alafenamide if prescribed by the doctor. Consult the doctor if you experience signs and symptoms of kidney damage such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not stop using any medications without consulting a doctor.
GentamicinTubocurarine
Severe
How does the drug interact with Gentarid Eye/Ear Drops 10 ml:
Co-administration of Gentarid Eye/Ear Drops 10 ml and Tubocurarine may increase the risk of side effects.
How to manage the interaction:
Co-administration of Gentarid Eye/Ear Drops 10 ml with Tubocurarine can possibly result in an interaction, but it can be taken if a doctor has advised it. If you have any of these symptoms, it's important to contact a doctor right away. These symptoms include having trouble breathing, feeling very weak or unable to breathe, not being able to move your muscles, having problems with your kidneys, having low levels of calcium in your body, or feeling very sick. Do not discontinue any medications without consulting a doctor.
Co-administration of Gentarid Eye/Ear Drops 10 ml and Tubocurarine may increase the risk of side effects.
How to manage the interaction:
Co-administration of Gentarid Eye/Ear Drops 10 ml with Tubocurarine can possibly result in an interaction, but it can be taken if a doctor has advised it. If you have any of these symptoms, it's important to contact a doctor right away. These symptoms include having trouble breathing, feeling very weak or unable to breathe, not being able to move your muscles, having problems with your kidneys, having low levels of calcium in your body, or feeling very sick. Do not discontinue any medications without consulting a doctor.
GentamicinVecuronium
Severe
How does the drug interact with Gentarid Eye/Ear Drops 10 ml:
Co-administration of Vecuronium with Gentarid Eye/Ear Drops 10 ml can make the treatment more effective.
How to manage the interaction:
Taking Vecuronium with Gentarid Eye/Ear Drops 10 ml together can possibly result in an interaction, but it can be taken if a doctor has advised it. If you have any of these symptoms - having trouble breathing or feeling like you can't catch your breath for a long time - it's important to call a doctor right away. Do not stop using any medications without a doctor's advice.
Co-administration of Vecuronium with Gentarid Eye/Ear Drops 10 ml can make the treatment more effective.
How to manage the interaction:
Taking Vecuronium with Gentarid Eye/Ear Drops 10 ml together can possibly result in an interaction, but it can be taken if a doctor has advised it. If you have any of these symptoms - having trouble breathing or feeling like you can't catch your breath for a long time - it's important to call a doctor right away. Do not stop using any medications without a doctor's advice.
GentamicinIopamidol
Severe
How does the drug interact with Gentarid Eye/Ear Drops 10 ml:
Co-administration of Iopamidol with Gentarid Eye/Ear Drops 10 ml may increase the risk of kidney problems.
How to manage the interaction:
Co-administration of Gentarid Eye/Ear Drops 10 ml with Iopamidol can possibly result in an interaction, but it can be taken if a doctor has advised it. It's important to keep an eye on how much you pee. If you notice any changes, like peeing more or less than usual, it's a good idea to let your doctor know right away. These changes could be a sign of problems with your kidneys, diabetes, or other health issues. Other symptoms to watch out for include feeling sick, throwing up, not wanting to eat, gaining or losing weight suddenly, or having trouble breathing. Do not stop using any medications without a doctor's advice.
Co-administration of Iopamidol with Gentarid Eye/Ear Drops 10 ml may increase the risk of kidney problems.
How to manage the interaction:
Co-administration of Gentarid Eye/Ear Drops 10 ml with Iopamidol can possibly result in an interaction, but it can be taken if a doctor has advised it. It's important to keep an eye on how much you pee. If you notice any changes, like peeing more or less than usual, it's a good idea to let your doctor know right away. These changes could be a sign of problems with your kidneys, diabetes, or other health issues. Other symptoms to watch out for include feeling sick, throwing up, not wanting to eat, gaining or losing weight suddenly, or having trouble breathing. Do not stop using any medications without a doctor's advice.
GentamicinBacitracin
Severe
How does the drug interact with Gentarid Eye/Ear Drops 10 ml:
Taking Gentarid Eye/Ear Drops 10 ml with bacitracin may increase the risk of serious side effects such as respiratory depression, kidney problems, and hearing loss.
How to manage the interaction:
Although there is a possible interaction, Gentarid Eye/Ear Drops 10 ml can be taken with bacitracin if prescribed by the doctor. Consult the prescriber if you experience hearing loss, ringing in the ears, vertigo, difficulty breathing, (or) signs and symptoms of kidney damage such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm.
Taking Gentarid Eye/Ear Drops 10 ml with bacitracin may increase the risk of serious side effects such as respiratory depression, kidney problems, and hearing loss.
How to manage the interaction:
Although there is a possible interaction, Gentarid Eye/Ear Drops 10 ml can be taken with bacitracin if prescribed by the doctor. Consult the prescriber if you experience hearing loss, ringing in the ears, vertigo, difficulty breathing, (or) signs and symptoms of kidney damage such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm.
GentamicinBotulinum toxin
Severe
How does the drug interact with Gentarid Eye/Ear Drops 10 ml:
Using Gentarid Eye/Ear Drops 10 ml with Botulinum toxin can increase the risk of side effects.
How to manage the interaction:
Although there is an interaction between Botulinum toxin and Gentarid Eye/Ear Drops 10 ml, they can be taken together if prescribed by a doctor. However, contact a doctor immediately if you experience muscle weakness or trouble breathing, swallowing, or speaking. Do not discontinue any medications without consulting a doctor.
Using Gentarid Eye/Ear Drops 10 ml with Botulinum toxin can increase the risk of side effects.
How to manage the interaction:
Although there is an interaction between Botulinum toxin and Gentarid Eye/Ear Drops 10 ml, they can be taken together if prescribed by a doctor. However, contact a doctor immediately if you experience muscle weakness or trouble breathing, swallowing, or speaking. Do not discontinue any medications without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
GENTAMICIN-0.3%W/VOther symptoms and signs involving the digestive system and abdomen
Severe
GENTAMICIN-0.3%W/VMyasthenia gravis and other myoneural disorders
Severe
Drug-Diseases Interactions
Login/Sign Up
GENTAMICIN-0.3%W/VOther symptoms and signs involving the digestive system and abdomen
Severe
How does the disease interact with Gentarid Eye/Ear Drops 10 ml:
Adequate hydration is critical for reducing the risk of oto- and nephrotoxicity associated with aminoglycoside usage. Dehydration should preferably be treated before starting therapy. Fluid status should be continuously maintained in patients who are at risk of dehydration, such as those who have severe and/or prolonged diarrhoea or vomiting. If indications of renal irritation appear during therapy, hydration should be increased as directed, followed by a dose reduction if necessary. If urine flow gradually decreases or azotemia worsens, therapy should be discontinued.
How to manage the interaction:
Dehydration should be corrected prior to initiation of therapy. Fluid status should be monitored closely in patients who may be at risk for dehydration, such as those with severe and/or prolonged diarrhea or vomiting. Therapy should be withdrawn if urinary output decreases progressively or azotemia (elevated levels of urea) increases.
Adequate hydration is critical for reducing the risk of oto- and nephrotoxicity associated with aminoglycoside usage. Dehydration should preferably be treated before starting therapy. Fluid status should be continuously maintained in patients who are at risk of dehydration, such as those who have severe and/or prolonged diarrhoea or vomiting. If indications of renal irritation appear during therapy, hydration should be increased as directed, followed by a dose reduction if necessary. If urine flow gradually decreases or azotemia worsens, therapy should be discontinued.
How to manage the interaction:
Dehydration should be corrected prior to initiation of therapy. Fluid status should be monitored closely in patients who may be at risk for dehydration, such as those with severe and/or prolonged diarrhea or vomiting. Therapy should be withdrawn if urinary output decreases progressively or azotemia (elevated levels of urea) increases.
GENTAMICIN-0.3%W/VMyasthenia gravis and other myoneural disorders
Severe
How does the disease interact with Gentarid Eye/Ear Drops 10 ml:
Aminoglycosides can elicit dose-related neuromuscular blockade and muscle weakness, especially in patients with neuromuscular illness or hypocalcemia, as well as in those undergoing general anaesthesia, neuromuscular blocking medications, or substantial transfusions of citrate-anticoagulated blood. Although neuromuscular blockade caused by aminoglycosides is usually self-limiting, it can occasionally result in respiratory paralysis. The most potent neuromuscular blocking drug in the class is regarded to be neomycin. However, the risk is greatest with large dosages instilled intraperitoneally or intrapleurally, or with fast intravenous administration of parenteral aminoglycosides. In patients with neuromuscular problems (e.g., myasthenia gravis, parkinsonian syndrome, botulism) or hypocalcemia, aminoglycoside therapy should be used with caution. If indications of respiratory paralysis appear during aminoglycoside therapy, the medicine should be stopped and, if necessary, mechanical breathing assistance administered.
How to manage the interaction:
Therapy should be administered cautiously in patients with neuromuscular disorders (e.g., myasthenia gravis, Parkinsonian syndrome, botulism) or hypocalcemia (low calcium levels). The drug should be discontinued and mechanical respiratory assistance provided if needed if signs of respiratory paralysis occur during therapy.
Aminoglycosides can elicit dose-related neuromuscular blockade and muscle weakness, especially in patients with neuromuscular illness or hypocalcemia, as well as in those undergoing general anaesthesia, neuromuscular blocking medications, or substantial transfusions of citrate-anticoagulated blood. Although neuromuscular blockade caused by aminoglycosides is usually self-limiting, it can occasionally result in respiratory paralysis. The most potent neuromuscular blocking drug in the class is regarded to be neomycin. However, the risk is greatest with large dosages instilled intraperitoneally or intrapleurally, or with fast intravenous administration of parenteral aminoglycosides. In patients with neuromuscular problems (e.g., myasthenia gravis, parkinsonian syndrome, botulism) or hypocalcemia, aminoglycoside therapy should be used with caution. If indications of respiratory paralysis appear during aminoglycoside therapy, the medicine should be stopped and, if necessary, mechanical breathing assistance administered.
How to manage the interaction:
Therapy should be administered cautiously in patients with neuromuscular disorders (e.g., myasthenia gravis, Parkinsonian syndrome, botulism) or hypocalcemia (low calcium levels). The drug should be discontinued and mechanical respiratory assistance provided if needed if signs of respiratory paralysis occur during therapy.
GENTAMICIN-0.3%W/VOther disorders of ear, not elsewhere classified
Severe
How does the disease interact with Gentarid Eye/Ear Drops 10 ml:
Aminoglycosides can harm the eighth cranial nerve, causing vestibular and/or auditory toxicity. Dizziness, nystagmus, vertigo, ataxia, tinnitus, and varied degrees of hearing impairment are among the symptoms. Following the discontinuation of the medicine, permanent hearing loss, including whole or partial irreversible bilateral deafness, may occur. Therapy with aminoglycosides, especially if extended (> 10 days), should be used with caution in patients with preexisting vestibular and/or auditory impairment, as it may delay or obfuscate the diagnosis of a drug-induced ototoxic impact. Patients should be adequately hydrated, the usual aminoglycoside dosage should not be exceeded, use with other ototoxic agents should be avoided, and peak and trough serum aminoglycoside concentrations should be determined on a regular basis and dosage adjusted to maintain desired levels.
How to manage the interaction:
Therapy should be administered with caution in patients with ototoxicity. The dosage should be reduced or therapy shoule be withdrawn if signs and symptoms of toxicity develop.
Aminoglycosides can harm the eighth cranial nerve, causing vestibular and/or auditory toxicity. Dizziness, nystagmus, vertigo, ataxia, tinnitus, and varied degrees of hearing impairment are among the symptoms. Following the discontinuation of the medicine, permanent hearing loss, including whole or partial irreversible bilateral deafness, may occur. Therapy with aminoglycosides, especially if extended (> 10 days), should be used with caution in patients with preexisting vestibular and/or auditory impairment, as it may delay or obfuscate the diagnosis of a drug-induced ototoxic impact. Patients should be adequately hydrated, the usual aminoglycoside dosage should not be exceeded, use with other ototoxic agents should be avoided, and peak and trough serum aminoglycoside concentrations should be determined on a regular basis and dosage adjusted to maintain desired levels.
How to manage the interaction:
Therapy should be administered with caution in patients with ototoxicity. The dosage should be reduced or therapy shoule be withdrawn if signs and symptoms of toxicity develop.
GENTAMICIN-0.3%W/VUnspecified kidney failure
Severe
How does the disease interact with Gentarid Eye/Ear Drops 10 ml:
Aminoglycosides have the potential to be ototoxic and nephrotoxic. Damage to the eighth cranial nerve can cause vestibular and/or auditory toxicities such as dizziness, nystagmus, vertigo, ataxia, tinnitus, and varied degrees of hearing impairment. Tubular necrosis, increases in BUN, nonprotein nitrogen, and serum creatinine concentration, decreases in urine specific gravity and creatinine clearance, proteinuria, and cells or casts in the urine are all signs of nephrotoxicity. Rarely, renal electrolyte wasting can cause hypocalcemia, hypomagnesemia, and hypokalemia, which can be accompanied with paresthesia, tetany, disorientation, and positive Chvostek and Trousseau symptoms. Although aminoglycoside-induced nephrotoxicity is often reversible after treatment withdrawal, mortality from uremia has happened on rare occasions. Patients with renal impairment should be treated with caution and at lower doses of aminoglycosides, as they may be at risk.Drug buildup increases the risk of oto- and nephrotoxicity. Patients should be adequately hydrated, the usual aminoglycoside dosage should not be exceeded, use with other neuro- and nephrotoxic agents should be avoided, and peak and trough serum aminoglycoside concentrations should be determined on a regular basis and dosage adjusted to maintain desired levels. If toxicity develops, renal and eighth cranial nerve function should be constantly monitored, and the dosage lowered or therapy discontinued.
How to manage the interaction:
Therapy should be administered cautiously at reduced dosages in patients with kidney impairment. Patients should be adequately hydrated, the dose should not be exceeded, and use with other neuro- and nephrotoxic agents should be avoided to minimize the risk of toxicity.
Aminoglycosides have the potential to be ototoxic and nephrotoxic. Damage to the eighth cranial nerve can cause vestibular and/or auditory toxicities such as dizziness, nystagmus, vertigo, ataxia, tinnitus, and varied degrees of hearing impairment. Tubular necrosis, increases in BUN, nonprotein nitrogen, and serum creatinine concentration, decreases in urine specific gravity and creatinine clearance, proteinuria, and cells or casts in the urine are all signs of nephrotoxicity. Rarely, renal electrolyte wasting can cause hypocalcemia, hypomagnesemia, and hypokalemia, which can be accompanied with paresthesia, tetany, disorientation, and positive Chvostek and Trousseau symptoms. Although aminoglycoside-induced nephrotoxicity is often reversible after treatment withdrawal, mortality from uremia has happened on rare occasions. Patients with renal impairment should be treated with caution and at lower doses of aminoglycosides, as they may be at risk.Drug buildup increases the risk of oto- and nephrotoxicity. Patients should be adequately hydrated, the usual aminoglycoside dosage should not be exceeded, use with other neuro- and nephrotoxic agents should be avoided, and peak and trough serum aminoglycoside concentrations should be determined on a regular basis and dosage adjusted to maintain desired levels. If toxicity develops, renal and eighth cranial nerve function should be constantly monitored, and the dosage lowered or therapy discontinued.
How to manage the interaction:
Therapy should be administered cautiously at reduced dosages in patients with kidney impairment. Patients should be adequately hydrated, the dose should not be exceeded, and use with other neuro- and nephrotoxic agents should be avoided to minimize the risk of toxicity.
Gentarid Eye/Ear Drops Substitute
G.Mycin Eye/Ear Drops
by Others
₹1.59per tabletGenticyn Eye/Ear Drops 10 ml
by Others
₹0.89per tabletGentasia Eye/Ear Drops
by Others
₹1.44per tabletRegenta Eye/Ear Drops 10 ml
by Others
₹1.35per tabletZonticin Eye/Ear Drop
by Others
₹0.99per tablet
Have a query?
